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INTRODUCTION
The key events in the development of the first skeletal muscles
of the vertebrate embryo are initiated and coordinated by the
myogenic regulatory factors (MRFs), Myf5 (Braun et al.,
1989), myogenin (Edmondson and Olson, 1989; Wright et al.,
1989), MyoD (Davis et al., 1987) and Mrf4 (Rhodes and
Konieczny, 1989; Braun et al., 1990; Miner and Wold, 1990),
all of which are members of the basic helix-loop-helix
super-family of transcription factors. Myf5 is the first MRF to
be expressed in birds (Hacker and Guthrie, 1998; Hirsinger et
al., 2001) and mammals (reviewed by Buckingham, 1992). In
mouse embryos, Myf5 expression starts in the trunk at 8.0 days
post coitum (dpc), followed by myogenin (Myog – Mouse
Genome Informatics; 8.5 dpc), Mrf4 (Myf6 – Mouse Genome
Informatics; 9.0 dpc) and MyoD (Myod1 – Mouse Genome
Informatics; 10.5 dpc). The first phase of Mrf4 expression
downregulates by 12.0 dpc, followed by a general upregulation
in a second foetal phase (Bober et al., 1991; Hinterberger et
al., 1991). In the developing limbs, Myf5 is again first (10.5
dpc), followed by the coincident expression of myogenin and
MyoD, and later of Mrf4. In the branchial arches, from which
some of the facial musculature originates, Myf5 is also
expressed first (9.5 dpc), followed a day later by MyoD and
myogenin; however, Mrf4 is only expressed in craniofacial
muscles during the later foetal phase. Analyses of mice mutant
for the MRFs, both singly and in combination (reviewed by
Arnold and Braun, 2000), are consistent with the notion that
Myf5 is the determination gene for skeletal muscle. Knowledge
of how Myf5 expression is induced and maintained is therefore
central to understanding the mechanisms of skeletal
myogenesis. The Myf5 and Mrf4 genes are linked in all
vertebrates analysed (Braun et al., 1990; Patapoutian et al.,
1993; Saitoh et al., 1993; O. Coutelle, C. Moreno de Barreda
and P. W. J. R., unpublished), raising the question of whether
these genes are coordinately controlled.
In vertebrate embryos, the somites are the source of the
skeletal muscles of the trunk and limb. As somites mature, they
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The muscle-specific transcription factors Myf5 and Mrf4
are two of the four myogenic regulatory factors involved
in the transcriptional cascade responsible for skeletal
myogenesis in the vertebrate embryo. Myf5 is the first of
these four genes to be expressed in the mouse. We have
previously described discrete enhancers that drive Myf5
expression in epaxial and hypaxial somites, branchial
arches and central nervous system, and argued that
additional elements are required for proper expression
(Summerbell, D., Ashby, P. R., Coutelle, O., Cox, D.,
Yee, S. P. and Rigby, P. W. J. (2000) Development 127,
3745-3757). We have now investigated the transcriptional
regulation of both Myf5 and Mrf4 using bacterial artificial
chromosome transgenesis. We show that a clone containing
Myf5 and 140 kb of upstream sequences is sufficient to
recapitulate the known expression patterns of both genes.
Our results confirm and reinforce the conclusion of our
earlier studies, that Myf5 expression is regulated differently
in each of a considerable number of populations of muscle
progenitors, and they begin to illuminate the evolutionary
origins of this complex regulation. We further show that
separate elements are involved in the activation and
maintenance of expression in the various precursor
populations, reflecting the diversity of the signals that
control myogenesis. Mrf4 expression requires at least four
elements, one of which may be shared with Myf5, providing
a possible explanation for the linkage of these genes
throughout vertebrate phylogeny. Further complexity is
revealed by the demonstration that elements which control
Mrf4 and Myf5 are embedded in an unrelated neighbouring
gene.
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divide into a mesenchymal sclerotome, from which the axial
skeleton originates, and an epithelial dermomyotome
(reviewed by Christ and Ordahl, 1995). Cells of the
dorsomedial lip of the dermomyotome migrate by involuting
immediately under the dermomyotome and give rise to the
dorsal myotome, which will form the epaxial muscles. In
thoracic somites, the ventrolateral lip of the dermomyotome
curves to form the somitic bud, which grows ventrally into the
lateral body wall, giving rise to the thoracic hypaxial muscles.
Muscle precursor cells detach from the medial edge of the
somitic bud to form the ventral myotome, while at limb-bud
levels, cells delaminate from the ventral dermomyotome and
migrate as mesenchymal cells into the limb. In occipital
somites, ventral dermomyotomal cells move into the
hypoglossal cord and migrate rostrally to form pharyngeal and
tongue muscles (Mackenzie et al., 1998). In the head, some
muscles form in situ from prechordal and paraxial mesoderm
(Couly et al., 1992), while other paraxial mesoderm-derived
muscle precursor cells first migrate into the branchial arches
from where they start a second migration to their final location
in the head (Noden, 1983).
Considerable attention has been focused upon the analysis
of regulatory elements controlling the MRF genes, as
identification of the cognate transcription factors will be
invaluable in elucidating the signals and mechanisms initiating
myogenesis. We have previously shown that Myf5 is regulated
through at least four discrete enhancers dispersed throughout
14.2 kb of the Mrf4/Myf5 locus (Summerbell et al., 2000).
These enhancers individually control the initiation of
expression in the epaxial and hypaxial domains of the somites,
a subset of the facial muscles and in the central nervous system.
However, they are unable, individually or together, to direct
expression in some hypaxial (limb, ventral myotome and
hypoglossal cord) and facial muscle populations, or to maintain
expression correctly, and they cause inappropriate expression
in the dermomyotome. Expression analyses of an lacZ-Myf5
reporter gene in chimaeric mouse embryos, generated by
transferring yeast artificial chromosomes (YACs) into
embryonic stem cells, had shown that the sequences required
for limb expression are situated far upstream of the gene
(Zweigerdt et al., 1997). Hadchouel et al. have mapped this
region to the - 58 to - 48 kb interval and shown that at least
one other upstream region is required for Myf5 expression
(Hadchouel et al., 2000). The regulation of Myf5 is thus
markedly different from that of myogenin or MyoD, which are
controlled by fewer elements that do not show the same
specificity for individual precursor cell populations (Cheng
et al., 1993; Yee and Rigby, 1993; Kablar et al., 1997;
Kucharczuk et al., 1999). We have previously argued that the
way in which Myf5 is regulated is particularly suited to its role
as the skeletal myogenic determination gene (Summerbell et
al., 2000).
The regulation of Mrf4 expression has been less intensively
studied. Transgenic analyses have shown that a 6.5 kb sequence
immediately upstream of the mouse Mrf4 gene recapitulates
the foetal phase of expression (Patapoutian et al., 1993), while
8.5 kb immediately upstream of rat Mrf4 drives both a subset
of the early somitic expression and the foetal phase (Pin et al.,
1997).
In order to identify and characterise all of the elements that
regulate the linked Mrf4 and Myf5 genes, we have isolated a
series of overlapping bacterial artificial chromosomes (BACs)
that constitute a de facto 5 ¢ deletion series of the region.
Using our modification of the protocol for homologous
recombination based manipulation of BAC clones (Yang et al.,
1997), alkaline phosphatase (AP) and lacZ reporter genes have
been introduced into the Mrf4 and Myf5 genes, respectively.
We show that transgenic animals carrying constructs
containing 140 kb upstream of Myf5 reproduce all known
aspects of the temporal and spatial expression patterns of both
genes. Using the 5 ¢ BAC deletion series, we locate additional
elements absent from our earlier plasmid-based constructs,
which drive Myf5 expression in individual branchial arches
and different hypaxial muscle progenitor populations, and
also sequences required for maintenance of expression.
Furthermore, we show that the regulation of Mrf4 expression
is also complex, with at least four separate elements required
to recapitulate the endogenous pattern. Our data are consistent
with the hypothesis that at least one element operates on both
genes.
MATERIALS AND METHODS
Isolation of BAC clones containing the Mrf4/Myf5 locus
Twelve bacterial artificial chromosome (BAC) clones were isolated
from a 129SV mouse library (Research Genetics, USA) by screening
filters simultaneously with two genomic probes derived from the third
exons of Mrf4 (458 bp) and Myf5 (435 bp). Six clones were confirmed
as true positives by PCR amplification using the following primers:
5¢ -CAGCACAGCATAGCACAGGAG-3¢ (Mrf4F), 5¢ -CTTTCACTT-
GAGGTGGTGAGA-3¢ (Mrf4R), 5¢ -CTGCAAAGTTTTACATCAG-3¢
(Myf5F) and 5 ¢ -ACCGAAAAGCACGTATTCTGC-3¢ (Myf5R).
Construction of shuttle vectors for homologous
recombination
BAC clones were modified by an improved version (J. J. C., D. C. and
P. W. J. R., unpublished) of another protocol (Yang et al., 1997). For
the modification of Myf5, we used reporter construct #3 of
Summerbell et al. (Summerbell et al., 2000), containing an nlacZ
(nuclear localization signal and lacZ) reporter gene followed by an
SV40 polyadenylation sequence cloned as a BamHI cassette into the
mutated translational start codon of Myf5. To construct the shuttle
vector (Yang et al., 1997), an NheI/SmaI fragment containing 1828 bp
and 1640 bp of homology 5¢ and 3¢ , respectively, to the translational
start codon of Myf5, and including the reporter cassette, was XhoI
linkered and cloned into the SalI site of the pSV1-RecA shuttle vector.
The AP-Mrf4 shuttle vector contains 1771 bp (HpaI/NlaIII) and 1546
bp (NlaIII/XbaI) of homology 5 ¢ and 3¢ , respectively, to the
translational start codon of the Mrf4 gene. The gene for human
placental alkaline phosphatase containing a membrane localisation
signal (gift from C. L. Cepko, Harvard Medical School, Boston,
Massachusetts, USA) followed by a PGK polyadenylation sequence
was cloned in frame into the translational start codon of the Mrf4 gene.
Full information on the cloning steps can be obtained on request.
Modification of BAC clones by homologous recombination
Chemically competent cells containing the appropriate BAC clone
were transformed with 10-100 ng of the appropriate shuttle vector,
plated and incubated at 30°C for 48 hours on LB-agar CAM/TET
plates (12.5 m g/ml chloramphenicol; 10 m g/ml tetracycline). Six
colonies were isolated and dispersed in 10 ml of LB and then 100 m l
of each were plated onto LB-agar CAM/TET plates and incubated at
43°C overnight. Single colonies were transferred to 3 ml of LB
(CAM/TET) and grown overnight at 43°C. Co-integrates were
identified by restriction mapping and hybridisation. One co-integrate
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colony was selected, streaked onto an LB-agar CAM-only plate and
grown overnight at 43°C. Four colonies were selected, dispersed into
1 ml of LB and diluted 1/100 in LB. 100 m l of these dilutions were
plated onto CAM/fusaric-acid plates (see Yang et al., 1997) and grown
at 37°C for 3 days. From these plates, 24 colonies were analysed by
digestion with EcoRI (for lacZ) or BamHI (for AP) to identify
fragments arising from the modification of the locus. Clones giving
the expected restriction pattern were further analysed by digestion
with a panel of enzymes (SalI, HindIII, EcoRI, BamHI), followed by
Southern blotting and hybridisation with probes corresponding to the
homology arms used in the appropriate shuttle vectors. 
Generation of transgenic mice
BAC DNA was prepared using the endonuclease-free QIAgen
maxiprep kit (QIAGEN Ltd., UK) following manufacturer’s
instructions with the following modifications: the volume of solutions
P1 (resuspension), P2 (lysis) and P3 (neutralisation) was increased
fivefold. DNA was eluted from the QIAgen column at 55°C using 15
ml of pre-heated elution buffer. After dialysis against microinjection
buffer (10 mM Tris-HCl pH 7.5, 0.1 mM EDTA pH 8.0 and 100 mM
NaCl), circular DNA was diluted to 1.5 ng/ m l in microinjection buffer
plus polyamines (final concentrations 30 m M spermine, 70 m M
spermidine; Montoliu et al., 1995) and used to inject fertilised mouse




Embryos were fixed overnight in Mirsky’s fixative (National
Diagnostics) at 4°C, washed three times in PBSA (Ca2+, Mg2+-free
phosphate buffered saline)/0.02% Nonidet P-40 for 20 minutes at
room temperature and placed in 10 ml of b -galactosidase staining
solution (5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6•3H2O, 2 mM MgCl2,
0.02% Nonidet P-40, 0.4 mg/ml X-Gal in PBSA) for 2-20 hours
(depending on the stage of the embryo) at room temperature, and
post-fixed in Mirsky’s fixative. In some instances, X-Gal was replaced
by Rose-Gal, Magenta-Gal or Bluo-Gal (Diagnostic Chemicals Ltd.,
Canada). 
AP staining
Embryos were fixed in 4% paraformaldehyde in PBSA overnight at
4°C, rinsed twice in PBSA +2 mM MgCl2, and washed in PBSA +2
mM MgCl2 for 10 minutes. Endogenous phosphatases were
inactivated by incubation for 1 hour in PBSA +2 mM MgCl2 at 65°C.
Embryos were equilibrated in AP-buffer (100 mM Tris-HCl pH 9.5,
100 mM NaCl, 50 mM MgCl2, 0.1% Tween 20) supplemented with
2 mM levamisol for 45 minutes at room temperature. Embryos were
washed once in ice-cold AP-buffer, transferred to AP-staining buffer
(AP-buffer plus 0.1 mg/ml of BCIP; 0.5 mg/ml NBT) and stained for
3-10 hours, depending on the stage of the embryo, in the dark at 4°C.
The reaction was stopped by washing the embryos in ice-cold PBSA
containing 2 mM EDTA in the dark at 4°C for 16-24 hours. Embryos
were post-fixed in Mirsky’s fixative adjusted to pH 5.0, in the dark at
4°C for 16 hours. 
RESULTS
We have previously shown that Myf5 is regulated by a number
of distinct and discrete enhancers, dispersed throughout 14.2
kb of the Mrf4/Myf5 locus. These enhancers separately initiate
expression in the epaxial muscle precursors, some hypaxial
precursors, some facial muscles and the central nervous
system, and cause incorrect expression in the dermomyotome.
Additional elements must be necessary to drive expression in
the limbs, ventral myotome, hypoglossal cord and the
remaining facial musculature, and to correctly maintain
expression (Summerbell et al., 2000). Individual elements
controlling Mrf4 transcription have not been defined, and only
a subset of the expression pattern has been reproduced using
transgenic analyses (Patapoutian et al., 1993; Pin et al., 1997),
again indicating that additional sequences are required.
In order to identify the additional regulatory elements
required for proper expression of both genes, six overlapping
BAC clones containing the locus were isolated from a murine
library. A physical map of the BAC contig (Fig. 1) was
generated using standard techniques. Clones were named
according to the sequence length (in kb) upstream of the
transcriptional start site of the Myf5 gene: BAC59, BAC61,
BAC81, BAC88, BAC140 and BAC195. Using the same
convention we will henceforth refer to construct #1 of
Summerbell et al. (Summerbell et al., 2000), containing 8.8 kb
of upstream sequences, as p8.8Z. Sequences 3 ¢ to the locus
range from 39.6 to ~50 kb downstream of the Myf5 gene
(5.4 kb for p8.8Z). Release of a C57BL6/J mouse BAC
clone sequence (GenBank Accession Number AC021642)
overlapping our contig was used to refine the location of most
of the BAC end-points to base-pair level. Analysis of this
sequence revealed the presence of the gene encoding the
protein tyrosine phosphatase RQ (Ptprq – Mouse Genome
Informatics; PTP-RQ), transcribed in the same orientation as
Mrf4 and Myf5. We identified and positioned 25 exons of the
gene representing 78.3% of the rat cDNA (GenBank Accession
Number AF063249), while 5 ¢ exons and upstream sequences
were not found within this BAC; a consensus polyadenylation
signal was located 31.1 kb upstream of Myf5. Other possible
coding regions were also identified (Fig. 1). Of particular
interest was EST AA060545 (GenBank) which contains
two exons with 100% homology to the genomic sequence
delimiting a putative intron flanked by consensus splice sites,
suggesting that this EST represents a true cDNA clone. If so,
the corresponding gene would overlap the gene for PTP-RQ
and be transcribed in the opposite orientation.
Generation of transgenic mice using modified BAC
clones
We modified the protocol for manipulating BACs by
homologous recombination in E. coli (Yang et al., 1997) in
order to increase the efficiency (J. J. C., D. C. and P. W. J. R.,
unpublished) and used it to introduce an nlacZ reporter cassette
into Myf5 (BAC-Z constructs) or both alkaline phosphatase
(AP) and nlacZ into Mrf4 and Myf5, respectively (BAC-APZ
constructs). These constructs were injected into fertilised
mouse eggs to generate transient embryos or transgenic lines.
We observed no significant differences in the expression
pattern of the nlacZ-Myf5 transgene between BAC-APZ and
BAC-Z lines from equivalent BAC clones, indicating that
AP-Mrf4 does not interfere with the expression of nlacZ-Myf5.
Copy number was assessed in five BAC59Z (3-10 copies) and
two BAC195Z (5-9 copies) lines and no correlation with
staining intensity was observed. A summary of the main
features of all the BAC transgenic lines is given in Table 1.
Identification of new Myf5 regulatory elements
Transgene expression in both BAC195Z and p8.8Z lines (Fig.
2A,B) started before 8.5 dpc in the dorsal dermomyotome of
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rostral somites, which is consistent with the epaxial enhancer
defined by Summerbell et al. (Summerbell et al., 2000)
correctly activating Myf5 expression. From 9.5 dpc, differences
between BAC195Z and p8.8Z became apparent. BAC195Z
lines expressed the transgene in the dorsal lip and the myotome
in all somites. In anterior thoracic somites we also saw
expression in the most ventral region of the dermomyotome,
corresponding to the early somitic bud (Fig. 2C, arrow). In
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Fig. 1. Physical map of the
Mrf4/Myf5 BAC contig. Distances
upstream and downstream from the
transcriptional start site of Myf5 are
indicated. The position and
orientation of the Mrf4 and Myf5
genes are indicated as red and blue
arrows, respectively. The p8.8Z
plasmid containing the proximal
control elements of Myf5
corresponds to construct #1
(Summerbell et al., 2000). Grey
indicates BACs not used in this
study. The sequenced BAC
AC021642 is represented in green
and shows the position of identified
ESTs (black boxes) and a long L1
repeat (yellow). Mapped exons
from the gene for protein tyrosine
phosphatase RQ (PTP-RQ) are
also represented. C, ClaI; E, EagI;
S, SalI; X, XhoI.
Table 1. Summary of the main features for all the BAC transgenic lines
nlacZ-Myf5 AP-Mrf4
Ventralmost Ventralmost 
Ventral tail thoracic Mandibular Ventral tail thoracic Copy 
Line somites somites arch Hyoid arch Maintenance somites somites number Other
BAC59Z.1 - - - + - na na 3 -
BAC59Z.2 Faint - Faint1 + - na na 7 -
BAC59Z.3 - - - + - na na 4 -
BAC59Z.4 - - - + - na na 10 -
BAC59Z.5 - - - + - na na 5 a
BAC59Z.6 - - - + - na na - b
BAC88Z.1 - - + + + na na - -
BAC195Z.1 + + + + + na na 5 -
BAC195Z.2 + + + + + na na 9 -
BAC195Z.3 + + + + + na na - -
BAC195Z.4 - - + + - na na - b
BAC195Z.5 - - Faint + - na na - b
BAC195Z.6 + + + + + na na - -
BAC59APZ.1 - - - + - - - - -
BAC59APZ.2 - - - + - - - - -
BAC59APZ.3 - - - + - - - - b
BAC88APZ.1 - - + + + - - - a
BAC88APZ.2 - - + + + ND - - -
BAC88APZ.3 + - + + + - ND - a, c
BAC140APZ.1 + + + + ND ND ND - -
BAC140APZ.2 + + + + + + + - d1
BAC140APZ.3 + + + + + + + - -
BAC140APZ.4 Faint Faint Faint Faint - + + - b
BAC195APZ.1 - - - - - ND ND - b
BAC195APZ.2 + Faint Faint Faint ND ND ND - b
BAC195APZ.3 + + + + + + + - -
BAC195APZ.4 + + + + + + + - d1
Epaxial somitic and limb expression were seen in all lines.
1Variable within littermates; a, ectopic dorsal root ganglia; b, low expression levels; c, nasal placodes; d, ectopic apical limb bud; na, not applicable; ND, not
done. 
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contrast, p8.8Z lines showed incorrect expression displaced
caudally in the dermomyotome (Fig. 2D, arrow). BAC195Z
lines expressed correctly in mandibular and hyoid arches (Fig.
2C, arrowheads), whereas p8.8Z activated the transgene only
in the hyoid (Fig. 2D, arrowhead).
At 10.5 dpc BAC195Z lines, unlike p8.8Z, expressed
the transgene in the forelimb (arrow), hypoglossal cord
(arrowheads) and the ventral half of the dermomyotome of
cervical and thoracic somites, corresponding to the somitic
bud (compare Fig. 2E with 2F). At 11.5 dpc
BAC195Z lines expressed the transgene in the
presumptive intercostal muscles including the
somitic bud (Fig. 2G, arrow) and derivatives of
the mandibular and hyoid arches in the head.
In contrast, p8.8Z lines (Fig. 2H) failed to
maintain expression in the intercostal region
and derivatives of the hyoid arch. At 12.5 dpc
BAC195Z lines (Fig. 2I) expressed strongly in
individual thoracic muscles (arrow), extraocular
muscles (black arrowhead), mandibular and
hyoid arch derivatives, and dorsal and ventral
tail somites (red arrowhead), while p8.8Z lines
(Fig. 2J) maintained expression only in dorsal
and central myotome. By 13.5 dpc transgene
expression was maintained strongly in all
muscle masses of BAC195Z lines (Fig. 2K) and
activated in the first row of snout muscles (Fig.
2K, arrow). In p8.8Z lines, the transgene was
expressed very faintly in the dorsal domain of
only a few tail somites (Fig. 2L, arrow). At 14.5
dpc BAC195Z lines expressed strongly in both
body and head muscles, including all the snout
musculature (Fig. 2M), while there was no
expression in p8.8Z lines (data not shown).
The last group of muscles to activate Myf5
expression were those of the eyelid (by 15.5
dpc, data not shown).
In summary, BAC195Z drives and maintains
transgene expression in dermomyotome and
myotome, hypoglossal cord, branchial arches,
and all epaxial, hypaxial, limb and head
muscles. It contains all the elements identified
as absent from p8.8Z (Summerbell et al., 2000)
and recapitulates all known aspects of the
expression pattern of Myf5 (Tajbakhsh et al.,
1996).
Analysis of Myf5 expression in the BAC
deletion series
In order to delimit the additional elements
identified in BAC195Z, we generated
transgenic lines using BAC140-, BAC88-
and BAC59-based constructs. Deletion from
BAC195APZ (or BAC195Z, Fig. 2) to
BAC140APZ did not change reporter gene
expression between 8.5 and 14.5 dpc (e.g. Fig.
3A,B; 10.0 dpc). We therefore have no evidence
for control elements lying within this 55 kb
interval.
Deletion from BAC140APZ to BAC88Z
positioned an element involved in expression in
the most ventral domain of the somites. This was best seen in
the thoracic somites during the 12 hour window between 28
and 36 somites (Fig. 3C; dotted line between the arrows,
compare with Fig. 3A,B), and in the tail at later stages (see
below). This positions a new element in the - 140 to - 88 kb
interval, setting the boundary for regulatory elements 140 kb
upstream of the Myf5 transcriptional start site, within the gene
for PTP-RQ.
Comparison between BAC88Z and BAC59APZ (or
Fig. 2. Timecourse of embryos containing Myf5 reporter
constructs BAC195Z and p8.8Z stained for b -galactosidase.
(A, BAC195Z; B, p8.8Z) Expression starts before 8.5 dpc.
(C,D) At 9.5 dpc dermomyotomal expression in BAC195Z is
evident in dorsal and ventral (arrow) somites while p8.8Z
lines show atypical caudal somitic expression (arrow).
BAC195Z lines express consistently in mandibular and hyoid
arches (arrowheads) while p8.8Z lines express consistently in
the hyoid only (arrowhead). (E,F) At 10.5 dpc BAC195Z
lines show hypoglossal cord (arrowheads) and forelimb
expression (arrow), absent in p8.8Z lines. (G,H) At 11.5 dpc expression in BAC195Z
is stronger than in p8.8Z lines, extending ventrally into the somitic bud (arrow).
Expression in hyoid arch derivatives starts to downregulate in p8.8Z lines. (I,J) At
12.5 dpc, thoracic (arrow) and extraocular muscles (black arrowhead) are visible in
BAC195Z lines. Expression in the tail occupies the entire length of the somites (red
arrowhead). Expression is only maintained in dorsal and central myotome in p8.8Z
lines, with tail expression restricted to the dorsal domain. (K,L) By 13.5 dpc,
transgene expression in BAC195Z lines expands in thoracic and facial domains,
including some snout muscles (arrow). Downregulation in p8.8Z lines is complete
except for residual tail expression (arrow). At 14.5 dpc (M) and later (not shown)
expression is maintained in BAC195Z lines and all snout musculature is now
expressing the transgene.
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BAC59Z) lines positioned the element(s) involved in
mandibular arch and hypoglossal cord expression, and in late
maintenance. While hyoid arch expression was consistent in
lines from both BACs, BAC59Z lines showed little or no
expression in the mandibular arch at any stage (compare Fig.
3C with 3D; arrowheads) and hypoglossal cord expression
was never seen. At 12.5 dpc (Fig. 3E), BAC88Z maintained
expression, whereas BAC59 lines downregulated reporter
expression in all muscles, except those of the limb (Fig. 3F).
This indicates that sequences required for activation in the
mandibular arch and the hypoglossal cord, and for maintenance
of expression in the axial musculature are located in the - 88
to - 59 kb interval, again within the gene for PTP-RQ.
Deletion from BAC59APZ to p8.8Z positioned elements
involved in dermomyotome, hyoid arch and limb expression.
At 9.5 dpc, p8.8Z lines (Fig. 2D) expressed the transgene
incorrectly in the caudal dermomyotome, whereas BAC59
lines did not (compare Fig. 2D (arrow) with Fig. 3D). Early
branchial arch expression in BAC59Z lines was very similar to
that in p8.8Z. However, while the latter downregulated arch
expression from 11.5 dpc (Fig. 2H), in BAC59Z lines it was
maintained through 13.5 dpc and then downregulated (data
not shown). In p8.8Z lines, transgene expression was never
activated in the limbs (Fig. 2H,J,L). These data indicate that
sequences in the - 59 to - 8.8 kb interval correct the
inappropriate dermomyotomal expression and drive expression
in the limbs at appropriate times and in the hyoid arch at late
stages.
The expression of Myf5 in tail musculature
Comparison of BAC lines that contain the element regulating
expression in the most ventral somitic domain (BAC195
and BAC140) and those lacking this region (BAC88 and
BAC59) shows that Myf5 expression is regulated
differentially in ventral and dorsal tail somites. In BAC195
and BAC140 lines, the transgene was expressed in all tail
somites at 12.5 dpc and 13.5 dpc (Fig. 4A,B). Somites I-VI
expressed nlacZ-Myf5 in the dorsal half, whereas older
somites expressed it in both dorsal and ventral halves. By
14.5 dpc (Fig. 4C), when the first myofibres appeared in the
tail, the transgene was strongly expressed in a characteristic
pattern, revealing dorsal and ventral muscles with a central
muscle population uniting the two components. Expression
in the tail was fully maintained and could be detected in
neonatal animals (data not shown). In contrast, in BAC88 and
BAC59 lines at 12.5 and 13.5 dpc, the transgene was first
expressed in somite VI or VII (Fig. 4D,E); expression was
confined to the dorsal region and disappeared as myofibres
arose in the tail (Fig. 4F).
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Fig. 3. Expression patterns in the BAC deletion series. (A,B) No
differences in expression pattern can be distinguished between
BAC195 (A) and BAC140 (B) lines. (C,D) Deletion to BAC88 (C)
abolishes expression in the ventral thoracic somites (dotted line
marks the ventral edge of the somitic bud at 10.0 dpc), while deletion
to BAC59 (D) abolishes expression in the mandibular arch
(arrowheads) and the hypoglossal cord. (E) At 12.5 dpc, transgene
expression is missing from the ventral half of the tail somites in
BAC88Z lines. (F) From 12.5 dpc, BAC59Z lines fail to maintain
transgene expression in axial musculature.
Fig. 4. Details of expression domains in the tail. BAC195Z lines
(A-C) show dorsal expression in all somites which extends to the
ventral edge as they mature, while in BAC59Z lines (D-F) initiation
of expression is delayed in the dorsal domain, does not extend across
the midline and is not maintained.
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Correlation between branchial arch and facial
expression patterns
At 10.0 dpc, BAC195, BAC140 and BAC88 (Fig. 3A-C)
constructs expressed the transgene in
mandibular and hyoid arches whereas
BAC59 lines only expressed reliably
in the hyoid arch (Fig. 3D). Fig. 5A-D illustrates the ontogeny
of the mandibular arch derivatives; Fig. 5E-H, by subtraction,
illustrates that of the hyoid arch derivatives
Fig. 5. Differences in branchial arch expression patterns.
BAC195Z expresses in mandibular and hyoid arches and
subsequently in all facial muscles (A-D) while BAC59Z
expresses only in the hyoid arch and in the facial
expression muscles at later stages (E-H). Comparisons at
different stages allow the mapping of derivatives from
mandibular (red arrowheads) and hyoid (black arrowheads)
arches. (A) At 9.5 dpc expression is first seen in the central
core of the mandibular arch. (B,C) By 10.5 dpc (B) this cell
population starts to migrate into the facial region and by
11.5 dpc (C) arrests midway between the eye and the
prospective ear. (D) From 12.5 dpc onwards this muscle
mass divides and expands to give rise to the muscles of
mastication. (E,F) At 9.5 dpc (E) the mesodermal core in
the hyoid arch is already expressing the transgene and by
10.5 dpc (F) starts dividing into two domains (x and y)
which begin migrating into the head region. (G) By 11.5
dpc the muscle mass separates into dorsal and ventral
branches. (H) From 12.5 dpc the dorsal branch populates
the region around the prospective ear, forming auricular
muscles, while the ventral branch migrates into the face,
forming muscles of facial expression.
Fig. 6. Analysis of Mrf4 expression
using double reporter gene constructs.
(A) Detail of a doubly stained 10.0 dpc
embryo from a BAC59APZ line.
Expression of both transgenes is visible
in the myotome. The different cellular
localisation signals of the two reporter
genes allow the visualisation of Mrf4
(AP, red arrowheads) and Myf5
(b -galactosidase, black arrowhead). At
9.5 dpc an early hypaxial domain of
AP-Mrf4 expression is detected in
BAC195APZ (B,E; black arrowhead)
and BAC140APZ (C,F; black
arrowhead) lines. Other somitic
expression is restricted to spindle
shaped myocytes in dorsal and ventral
myotome (E,F; red arrowheads), which
is the only expression domain in
BAC88APZ lines (D,G). At 11.5 dpc,
BAC195APZ lines (H) express the
AP-Mrf4 transgene in the most ventral
part of the thoracic somites (arrowhead)
which is not seen in BAC88APZ (not
shown) or BAC59APZ (I, arrow) lines.
In both cases the dotted line marks the
ventral edge of the somites. (J,K)
Expression is downregulated at 12.5 dpc
in BAC140APZ (J) and BAC59APZ
lines (K) and upregulated in limb buds
(black arrowheads). (L,M) Expression
in the tail occupies the entire myotome
in BAC140APZ lines (L) but is
restricted to the dorsal half in BAC59APZ (not shown) and BAC88APZ lines (M). At 13.5 dpc expression is maintained in limb muscles
(N, arrowhead) and activated in the pinna of the ear (O, arrowhead) in BAC59APZ and BAC195APZ (not shown).
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Mandibular arch muscle progenitors (Fig. 5A-D; red
arrowheads) migrated as a single condensation to a position
midway between the presumptive eye and the ear (11.5 dpc).
The first fibres could be seen, running in a dorsoventral
direction, as the cells separated into individual groups (12.5
dpc and later) which will form the muscles of mastication.
Hyoid arch muscle progenitors (Fig. 5E-H; black
arrowheads) migrated out of the arch from 10.5 dpc, splitting
into dorsal (x) and ventral (y) branches by 11.5 dpc. The dorsal
domain divided further at 12.5 dpc and gave rise to the external
muscles of the ear (x), while the ventral domain elongated
rostrally and separated into dorsal and ventral branches (y)
which did not divide into different muscle masses until 13.5
dpc (data not shown). These branches expanded towards the
snout and the eye regions where they will form the muscles of
facial expression.
Double reporter-gene BAC constructs
The introduction of two reporter genes into a single BAC
enabled us to analyse and compare the expression patterns of
Mrf4 and Myf5 in the same genomic context and in the same
embryo. Double BCIP/NBT (red) and X-gal (blue) staining
allowed us to clearly identify the locations of AP-Mrf4
(membrane bound) and nlacZ-Myf5 (nuclear localised)
transgene expression. Fig. 6A shows the double expression
pattern in thoracic somites in a BAC59APZ embryo at 10.0 dpc
(32 somites). The Myf5 reporter marked the nuclei of the
myotomal cells, aligned at the centre of the myoblasts, while
the Mrf4 reporter stained the surrounding membrane,
occupying the entire width of the myotome. Sectioning
through doubly or singly stained embryos showed Mrf4-
transgene expression restricted to the myotome, while the
Myf5-transgene was expressed in myotome and dorsal
dermomyotome (data not shown). In practice, we usually
compared littermates stained independently for AP or
b -galactosidase, which allows the detection of the more
delicate details of the expression patterns of both transgenes.
Identification of a distal regulatory region driving
ventral Mrf4 expression
There are two phases of Mrf4 expression during development:
an early one restricted to embryonic myotome and a late one
in foetal skeletal muscle (Bober et al., 1991; Hinterberger et
al., 1991). Plasmid-based transgenic analyses have reproduced
only a subset of the full expression pattern (Patapoutian et al.,
1993; Pin et al., 1997).
AP-Mrf4 expression was first detected in all BAC transgenic
lines at 9.0 dpc in the central part of the myotome of rostral
somites; it extended rapidly in a rostrocaudal sequence along
the body axis and both dorsally and ventrally within individual
somites. We observed no differences in AP-Mrf4 expression
between BAC195 and BAC140 lines at any stage analysed.
BAC195APZ (Fig. 6B,E) and BAC140APZ (Fig. 6C,F) lines
revealed a new ventral domain of expression in anterior
thoracic somites at 9.5 dpc (24-28 somite stage) and earlier,
confirming our recent in situ hybridisation data (D. S., C. Halai
and P. W. J. R., unpublished). Unlike Mrf4-expressing cells in
dorsal myotome, these cells were not spindle shaped (Fig.
6E,F; compare red and black arrowheads). This ventral domain
of expression was missing in BAC88APZ (Fig. 6D,G) and
BAC59APZ (data not shown) lines. At the 38-44 somite stage
(10.5 dpc-11.0 dpc), BAC195APZ (Fig. 6H) and BAC140APZ
(data not shown) lines expressed the transgene throughout the
myotome and the somitic bud while in BAC88APZ (data not
shown) and BAC59APZ lines expression was absent in the
most ventral portion of the thoracic somites (Fig. 6I). At 12.5
dpc, BAC195APZ and BAC140APZ (Fig. 6J,L) lines showed
dorsal and ventral expression in tail somites, but in BAC88APZ
(Fig. 6M) and BAC59APZ (Fig. 6K) lines this expression was
restricted to the dorsal domain. Thus, a ventral domain control
region is located in the - 140 to - 88.2 kb interval, overlapping
an element that drives equivalent ventral Myf5 expression (see
above).
The first phase of AP-Mrf4 expression downregulated from
12.0 dpc, in agreement with previous in situ hybridisation data
(Bober et al., 1991; Hinterberger et al., 1991). However, the
second phase of expression commenced earlier than reported;
it started in both fore- and hindlimbs before 12.5 dpc
(Fig. 6J,K; black arrowheads) and increased in intensity in
subsequent stages (e.g. Fig. 6N, arrowhead). By 13.5 dpc
expression could also be detected in the pinna of the ear
muscles (Fig. 6O, arrowhead). There was a generalised
upregulation of the transgene from 14.5 dpc (data not shown). 
DISCUSSION
We have previously shown that Myf5 expression is regulated
by a number of discrete enhancers in a 14.2 kb region that
spans the Mrf4/Myf5 locus, and that each of these enhancers is
specific for a particular population of muscle precursor cells
(Summerbell et al., 2000). These data also made it clear that
there must be other elements, remote from the locus, that
control important aspects of the expression pattern of the gene.
We have now turned to BAC transgenesis, using clones
modified by homologous recombination in E. coli, to identify
those missing elements and show that a BAC that contains 140
kb upstream of the Myf5 gene is capable of recapitulating the
complete expression patterns of both Mrf4 and Myf5. The
results confirm and reinforce the main conclusion of our
plasmid-based studies, namely that Myf5 expression is
independently regulated in each of a large number of
populations of muscle progenitors, and they begin to illuminate
the evolutionary origins of this complex regulation. Further
complexity is revealed by our demonstration that elements
controlling Mrf4 and Myf5 are embedded in a neighbouring
gene, which is apparently not expressed in muscle. In addition,
Mrf4 and Myf5 are expressed at the same time in the ventral
domain of the thoracic and tail somites, suggesting that Mrf4
acts earlier in muscle development than previously thought.
Strikingly, we show that this particular aspect of the expression
pattern of both genes is regulated by sequences in the same
genomic interval, raising the possibility that a single element
could control both genes.
The multiplicity of Myf5 regulatory elements
Analysis of a number of BACs from the contig, which
constitute a de facto 5¢ deletion series, allowed us to localise
sequences controlling particular aspects of the expression
pattern of Myf5. In a parallel series of experiments, Hadchouel
et al. used YAC transgenesis to analyse Myf5 regulation
(Hadchouel et al., 2000); the end-points of their YACs and our
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BACs are usefully different. Thus, by comparing these data
sets, and also using the earlier results of Zweigerdt et al.
(Zweigerdt et al., 1997), we can further delimit these elements
(Fig. 7).
The - 140 to - 88.2 kb region is required for Myf5 expression
in the ventral domain of tail somites and the most ventral
component of thoracic somites, the developing somitic bud.
Expression in the thoracic ventral domain is particularly
dynamic, and it is necessary to focus on the 12 hour interval
between 28 and 36 somites, while expression in the tail ventral
domain is seen only from 12.5 dpc onwards. Hadchouel et al.
suggest that all the sequences required for full Myf5 expression
are contained within 96 kb upstream of the gene, but they did
not show data for these time intervals (Hadchouel et al., 2000).
A YAC clone containing approximately 95 kb upstream of the
Myf5 gene was not able to drive this ventral somitic expression
in the tail at 12.5 dpc (see Fig. 4B in Zweigerdt et al., 1997)
but the missing expression domain could be due to the
chimaeric nature of these embryos. Therefore the available data
do not allow us to refine the position of this element further.
The - 88.2 to - 58.6 kb region directs consistent expression
in the mandibular arch and hypoglossal cord, and is required
to maintain expression levels in axial muscles from 11.5 dpc
onwards. A YAC containing 63 kb of upstream sequences is
not able to drive these aspects of the expression pattern
(Hadchouel et al., 2000), localising the required element(s) to
the - 88.2 to - 63 kb interval.
In the - 58.6 to - 8.8 kb region lie elements that direct
expression in the limbs, block the suppression of late
hyoid arch expression and suppress the inappropriate
dermomyotomal expression seen in p8.8Z lines (Summerbell
et al., 2000). Hadchouel et al. (Hadchouel et al., 2000) have
localised the limb element to between - 58 and -48 kb, a
conclusion that is consistent with Zweigerdt et al. (1997) and
our own data. Late hyoid arch expression is seen with a - 45
kb YAC (Fig. 2D in Zweigerdt at al., 1997) but not with one
of - 23 kb (Fig. 6B in Hadchouel et al., 2000); thus by
combining the data sets we can localise this element to between
- 45 and - 23 kb.
The diversity of regulatory elements parallels the
heterogeneity of somite-derived muscle precursors
Initiation of somitic expression
Proper expression in the somites requires at least four elements,
one of which acts negatively. We previously defined two
enhancers, one specific for the epaxial domain, one for the
hypaxial (Summerbell et al., 2000). The epaxial enhancer acts
in the dorsal lip of the dermomyotome and the dorsal-most
myotome (Fig. 2B and Summerbell et al., 2000). None of our
data indicate a requirement for an additional element in the
initiation of epaxial expression. The hypaxial enhancer located
within the Myf5 gene drives a subset of the early hypaxial
pattern; while the timing is correct the location within the
ventral somite is not and the transgene is activated in caudal
dermomyotome (Fig. 2D and Summerbell et al., 2000). This
indicates that an element elsewhere within the locus normally
prevents expression in this region. The present data show that
this negatively acting element is within BAC59, but full
Fig. 7. Summary of the expression
domains and regulatory regions
for both Mrf4 and Myf5.
(A,B) Regulatory regions for Mrf4
(A) and Myf5 (B) are colour coded
and their anatomical expression
domains are represented below at
early and late stages of
development (C, Mrf4;
D, Myf5).The ventral somite or
somitic bud (red) region may
contain a single element which
controls both genes. The negative
arch (green hatched) region
suppresses late Myf5 arch
expression in p8.8Z lines but in
the context of the locus may be
involved in shielding the Mrf4
promoter from the arch elements.
The map is not to scale. §,
approximate YAC ends (Zweigerdt
et al., 1997); ◊, YAC ends
(Hadchouel et al., 2000); ‡, rat
genomic distance (Pin et al.,
1997); †, restriction enzyme
boundaries of plasmid constructs
(Patapoutian et al. (1993); B,
BamHI; Bs, BsaBI; K, KpnI; N,
NcoI; Nd, NdeI; Nh, NheI; X,
XbaI; Xm, XmnI.
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hypaxial expression is obtained only with BAC140, which
carries the distal ventral element (see above). Thus, correct
hypaxial expression probably requires the interaction of two
positively acting elements that control initial activation,
together with the negative element that prevents inappropriate
dermomyotomal expression.
Hypaxial-derived muscle progenitors
The hypaxial muscle precursors give rise to a diversity of
muscle populations, those of the limb, trunk, pharynx and
tongue. In limb muscle progenitors myogenesis is delayed
such that Myf5 is not activated until after migration. Myf5- /-
embryos show a 2.5 day delay in the activation of the myogenic
programme in the axial musculature but the timing of limb
myogenesis is not affected (Kablar et al., 1997). While in the
trunk and the head multiple interacting elements are involved
in initiation of expression in different muscle precursors, and
an additional region(s) is required to cooperate with these in
the maintenance of the expression levels, the available data do
not subdivide the regulation of limb expression in the same
manner and do not suggest interaction between its control
region and others. This is consistent with the view that limb
and axial muscles are controlled by separate circuits.
The progenitors of the ventral-most thoracic muscles express
both Mrf4 and Myf5 early in myogenesis, and give rise to
hypaxial musculature by elongation rather than migration. The
first wave of myoblasts originates from ventral dermomyotome
and elongation of the hypaxial myotome is then accomplished
by the intercalation of second wave myoblasts derived from the
four lips of the dermomyotome (Cinnamon et al., 1999). In this
subset of hypaxial precursors the expression of both genes is
controlled by an element, or elements, contained in the same
genomic interval. In addition we observe a correlation between
early ventral thoracic expression and later expression along the
entire dorsoventral axis of the hypaxial domain, suggesting that
this element(s) may be responsible for gene activation in
second wave myoblasts.
Another group of hypaxial muscle precursors is formed by
the progenitors of the pharyngeal and tongue muscles, which
arise from the hypaxial domain of occipital somites that
express Myf5, MyoD and myogenin (but not Mrf4) throughout
their migration. Myf5 expression in this population is regulated
by a separate element in the - 88.2 to - 63 kb region.
There is thus a striking correlation between the
heterogeneity of hypaxial muscle precursors and the diversity
of elements required for proper Myf5 regulation, suggesting
that the emergence of the different hypaxial muscle groups
during vertebrate evolution was paralleled by the acquisition
of new regulatory sequences able to interpret the new
signalling environments that initiate myogenesis.
Branchial arch expression of Myf5 and the ontogeny
of the facial musculature
The regulation of Myf5 expression in the facial muscle
precursors is also complex. We have previously defined a
proximal enhancer between Mrf4 and Myf5 that is capable of
driving consistent expression in the hyoid arch but only variable
expression in the mandibular arch, and an intragenic enhancer,
acting primarily in the hypaxial domain of the somites, that can
also direct weak expression in the arches from 9.0 to 10.25 dpc.
In the context of p8.8Z, expression is downregulated from 12.5
dpc and we defined this negative element as overlapping the
epaxial enhancer and the Mrf4 gene (Patapoutian et al., 1993;
Summerbell et al., 2000). The activity of the intergenic
enhancer is not maintained from 11.5 dpc by a YAC containing
23 kb of upstream DNA (Fig. 6C,D in Hadchouel et al., 2000)
but late hyoid arch expression is restored in BAC59 lines and
mandibular arch expression becomes reliable in BAC88 lines.
We can thus define five elements involved in proper expression
in the arches. The negative element that overlaps Mrf4
antagonises the early arch enhancer at later times; the activity
of this element would then be over-ridden in the mandibular and
hyoid arches by elements located in the - 88.2 to - 63 kb and
the - 45 to - 23 kb regions, respectively. This arrangement of
multiple regulatory elements probably reflects the highly
complex signalling environment present during facial
development (for a review, see Francis-West et al., 1998).
The fact that Myf5 expression is independently controlled in
the different arches allows us to follow the development of
muscles derived from the hyoid arch in BAC59 lines and, by
subtraction, those derived from the mandibular arch in lines
carrying the larger BACs. In the avian embryo, paraxial
mesoderm migrates into the branchial arches and the
contribution of these precursors to facial muscles is well
documented (Hacker and Guthrie, 1998; Noden et al., 1999).
Although it is assumed that mammalian craniofacial muscle
development follows the same programme, few data are
available, and these mostly focus on the first migration of
paraxial mesoderm cells into the arches (Trainor et al., 1994;
Trainor and Tam, 1995). We have now looked at those cells that
express Myf5 in the branchial arches and their derivatives at
successive developmental stages and conclude that muscles
involved in mastication derive from the mandibular, while
muscles involved in facial expression originate in the hyoid.
Thus their ontogeny is generally equivalent to that described by
Noden et al. for the chick (Noden et al., 1999). However, we
have identified an important difference in the behaviour of a
subset of the cells that populate the hyoid arch. The population
of mesodermal cells in the core of the arch splits into dorsal and
ventral domains; the dorsal domain gives rise to the external
muscles of the ear (Fig. 5E-H). Noden et al. also describe two
groups of Myf5-expressing cells in the hyoid arch, the dorsal
group located in close proximity to the otic vesicle (Noden et
al., 1999). However, this cell population subsequently becomes
incorporated into the larger ventral cell population of the arch,
which will give rise to the mandibular depressor, among other
muscles. During early evolution of mammals the retroarticular
process and the attached mandibular depressor were lost
(Köntges and Lumsden, 1996). It is interesting to speculate that
this released the progenitor cells destined to form this muscle,
which subsequently acquired the capacity to form the external
musculature of the ear. 
Mrf4 expression is regulated by elements
interdigitated between those that control Myf5
By inserting a second reporter gene into the BACs we show
that the regulation of Mrf4 expression is also complex.
Sequences between - 15.3 and - 8.8 kb are required for limb
expression and for the second phase of gene activity
(Patapoutian et al., 1993) and sequences between - 17.3 and
- 15.3 kb drive early expression in the central myotome of
thoracic somites (Fig. 2A in Pin et al., 1997).
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In BAC-APZ lines, AP-Mrf4 expression is first detected in
the central part of the myotome, where it is confined to
differentiated myocytes, and then expands dorsally and
ventrally within the myotome, as the epaxial and hypaxial
domains grow dorsomedially and ventrolaterally, respectively
(Denetclaw and Ordahl, 2000). We also show that sequences
within BAC59 drive strong expression in rostral, thoracic and
caudal somites, indicating that myotomal expression is
controlled by at least two separate elements: one proximal,
driving only central myotome expression at thoracic levels, as
previously described (Pin et al., 1997); and one distal (between
- 58.6 and - 17.3 kb), driving the remaining somitic expression.
The - 140 to - 88.2 kb region is required for Mrf4 and Myf5
expression in the most ventral part of thoracic somites. There
are striking similarities in the expression patterns of the two
genes, and their regulation, in this set of precursors: (1)
activation of expression in the ventral dermomyotome of
thoracic somites is very similar temporally and spatially; (2)
lack of early ventral expression correlates with the absence or
reduction of transgene expression in the somitic bud at later
stages; and (3) expression in tail somites is regulated
independently in the dorsal and ventral domains. These
observations raise the exciting possibility that a single element
is acting simultaneously on both genes. The two genes have
been linked throughout vertebrate evolution, and form a
syntenic group in teleost fish (O. Coutelle, C. Moreno de
Barreda and P. W. J. R., unpublished), birds (Saitoh et al.,
1993) and mammals (Braun et al., 1990; Patapoutian et al.,
1993). This linkage may have been maintained by
co-regulation of this aspect of the expression patterns of the
genes. The coincident activation of the two genes in this
domain suggests that Mrf4 may not be functionally
downstream of Myf5 and that in this case it might act earlier
in myogenesis than previously thought.
Complexity in the regulation of the Mrf4/Myf5 locus
Myf5 is the first myogenic regulatory factor gene to be activated
during mouse development. We have previously proposed that
the complex architecture of its regulatory elements reflects its
special function and is required to interpret the distinct
signalling environments that initiate myogenesis in the various
progenitor populations (Summerbell et al., 2000). The present
data strongly support this view. We have now demonstrated that
the regulation of Mrf4 is also complex, and that the elements
that control the two genes are interspersed, raising the question
of how they distinguish between the two promoters to give
generally distinct expression patterns. This is complicated
further by the observation that many of these regulatory
elements are within the adjacent gene for PTP-RQ, which is
expressed in the glomerular mesangial cells of the kidney
(Wright et al., 1998) and does not appear to be expressed at
appreciable levels in skeletal muscle precursors (J. J. C.,
C. Halai and P. W. J. R., unpublished). This indicates a
requirement for transcriptional insulators to shield the
promoter of the PTP-RQ gene from the regulatory elements
controlling Mrf4 and Myf5 expression, and vice versa. It is,
however, of considerable interest to note that kidney mesangial
cells are myofibroblasts that express many genes normally
thought of as muscle specific, including MyoD and myogenin
(Mayer and Leinwand, 1997).
The promoters and the distal control elements must have
evolved so that Mrf4 expression cannot be activated by signals
directed at Myf5, and vice versa, and the elucidation of the
mechanisms underlying this specificity will be a major topic
of future research. The multiplicity of elements controlling
branchial arch expression will provide a good model because
in the complex environment of the arches only Myf5 is
expressed, despite the fact that some of the necessary elements
are physically closer to Mrf4. The negatively acting Myf5
element that we have mapped as overlapping Mrf4 may well
be involved in shielding the latter from the arch elements but
when we varied the context it interfered with Myf5 expression
in p8.8Z lines. Similarly, Hadchouel et al. have shown that
sequences from - 58 to - 48 kb, when juxtaposed to the
intergenic arch enhancer and a Myf5 minimal promoter, can
direct expression in limbs, arches, hypoglossal cord, and
both epaxial and hypaxial components of the myotome, and
conclude that many of the sequences important for proper Myf5
regulation are within this 10 kb interval (Hadchouel et al.,
2000). As we have previously shown that elements outwith this
segment function as enhancers in the epaxial and hypaxial
domains, this raises the possibility of redundancy. However, it
is important to consider two aspects of the expression pattern
driven by this 10 kb region (see Fig. 7B in Hadchouel et al.,
2000): (1) in thoracic somites transgene expression is strong in
the dorsal and ventral myotome but weaker in the centre, a
characteristic of the Mrf4 element that we have localised to the
- 58.6 to - 17.3 kb interval; and (2) there is a delay in expression
in tail somites, with only the first five caudal somites from the
hindlimb expressing the transgene dorsally at 11.5 dpc,
mimicking the pattern of Mrf4 expression in caudal somites at
this stage. It is thus possible that the - 58 to - 48 kb interval
contains some Myf5-specific elements, e.g. the one that acts in
the limb, together with elements that can act on Myf5 when
juxtaposed to it, but which in the context of the locus act on
Mrf4. Equally, an element in this interval may act on both
genes, like the upstream ventral element described above.
The presently available data open the way to a precise
definition of all of the elements that control Myf5 and thus to
the identification of the cognate transcription factors and the
signals that regulate them. Such work will reveal the rich
diversity of signalling environments that are capable of
initiating myogenesis in the multiple progenitor populations
present in the embryo. It will be of interest to conduct parallel
studies in other organisms in order to try to discern how this
complex regulation evolved. However it arose, it will be a
considerable challenge to understand how these two linked
genes are controlled so that their expression patterns are
sometimes distinct and sometimes overlapping. 
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